Novartis, zeroing in on innovative meds, launches strategic review of India outfit aliu Fri, 02/16/2024 – 14:35 More: Novartis, zeroing in on innovative meds, launches strategic review of India outfit Source: fierce
read moreFDA approves Roche, Novartis’ Xolair to prevent severe outcomes from common food allergies kdunleavy Fri, 02/16/2024 – 13:03 More: FDA approves Roche, Novartis' Xolair to prevent severe outcomes from common food allergies Source: fierce
read moreSarepta’s Elevidys expansion bid nabs FDA priority review, with no adcomm planned zbecker Fri, 02/16/2024 – 10:33 More: Sarepta's Elevidys expansion bid nabs FDA priority review, with no adcomm planned Source: fierce
read moreFollowing FDA rejection, Sanofi and Regeneron’s Dupixent gains Japanese approval in hives condition kdunleavy Fri, 02/16/2024 – 10:31 More: Following FDA rejection, Sanofi and Regeneron's Dupixent gains Japanese approval in hives condition Source: fierce
read moreJ&J consumer health spinoff Kenvue telegraphs 100-plus layoffs in California, New Jersey fkansteiner Fri, 02/16/2024 – 09:39 More: J&J consumer health spinoff Kenvue telegraphs 100-plus layoffs in California, New Jersey Source: fierce
read moreCardiac quantitative susceptibility mapping successfully visualised iron deposits in patients More: Researchers investigate new technique for diagnosing cardiac conditions Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals